Healthcare & Life Sciences
Sparrow Pharmaceuticals
United Statessparrowpharma.com
Sparrow Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
activeseries-b
series-b
Stage
2020
Founded
2
Investors
About Sparrow Pharmaceuticals
Based in the United States, Sparrow Pharmaceuticals is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Sparrow Pharmaceuticals is a clinical-stage biotechnology company developing novel, targeted therapies for serious autoimmune and inflammatory conditions. Their lead product candidate, SPI-62, is an HSD-1 inhibitor currently in Phase 2 clinical trials.
Explore Sparrow Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.